Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV
Clinical trial NCT04540627 · COMPLETED
Trial details
- NCT number
- NCT04540627
- Sponsor
- mAbxience Research S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2020-10-23
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.